1. 119TiP An observational study to assess the effectiveness and safety of cemiplimab in patients with advanced non-small cell lung cancer (NSCLC) in routine clinical practice within Europe (CEMI-LUNG). (December 2022) Authors: Gessner, C.; Griesinger, F.; Shah, R.; Talbot, T.; Venkateshan, S.; Vadanahalli Shankar, A.K.; Seluzhytsky, A.; Marsden, D.M. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3056 Influence of maintenance therapy on incidence of 2nd line therapy and OS in NSCLC IV. (September 2015) Authors: Lüers, A.; Neemann, N.; Prenzel, R.; Scriba, D.; Hoheisel, M.; Wedeken, K.; Willborn, K.; Griesinger, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3119 P53 disruptive mutation is a negative predictive factor in EGFR M+ NSCLC treated with TKI. (September 2015) Authors: Lüers, A.; Neemann, N.; Prenzel, R.; Scriba, D.; Willborn, K.; Stropiep, U.; Falk, M.; Hallas, C.; Tiemann, M.; Griesinger, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3134 Incidence of driver mutations in lung adenocarcinomas: Rural versus industrialized environment. (September 2015) Authors: Falk, M.; Baumhardt, M.; Griesinger, F.; Lüers, A.; Wiest, G.H.; Tiemann, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?: Statement of the Germany Society for Pathology (DGP) and the Working Group Thoracic Oncology (AIO) of the German Cancer Society e.V. (Stellungnahme der Deutschen Gesellschaft für Pathologie und der AG Thorakale Onkologie der Arbeitsgemeinschaft Onkologie/Deutsche Krebsgesellschaft e.V.). (January 2017) Authors: von Laffert, M.; Schirmacher, P.; Warth, A.; Weichert, W.; Büttner, R.; Huber, R.M.; Wolf, J.; Griesinger, F.; Dietel, M.; Grohé, Ch. Journal: Lung cancer Issue: Volume 103(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Brigatinib versus crizotinib in patients with ALK inhibitor–naive advanced ALK+ NSCLC: results from the phase 3 ALTA-1L trial. (January 2020) Authors: Califano, R.; Camidge, D.; Kim, H.-R.; Ahn, M.-J.; Yang, J.; Han, J.-Y.; Hochmair, M.; Lee, K.H.; Delmonte, A.; Campelo, M.R. Garcia; Kim, D.-W.; Griesinger, F.; Felip, E.; Spira, A.; Gettinger, S.; Tiseo, M.; Ni, Q.; Zhang, P.; Popat, S. Journal: Lung cancer Issue: Volume 139(2020)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of therapeutically targetable genomic alterations in a cohort of patients with CUP using a hybrid-capture based next generation sequencing assay. (December 2016) Authors: Menon, R.; Mueller, J.; Lakis, S.; Hube, A.; Bochtler, T.; Wesseler, C.; Griesinger, F.; Loeffler, H.; Langenbuch, T.; Brandts, C.; Garcia, A.P.; Krämer, A.; Heuckmann, J.; Heukamp, L. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PROSPECTIVE MULTICENTER REGISTRY FOR SECONDARY CNS INVOLVEMENT IN MALIGNANT LYMPHOMA: AN UPDATE WITH DATA FROM 181 PATIENTS. (12th June 2019) Authors: Lammer, F.; May, L.; Martus, P.; Schroers, R.; Schlegel, U.; Hofer, S.; Bairey, O.; Schmitz, N.; Griesinger, F.; Schmidt‐Hieber, M.; Weißinger, F.; Reimer, P.; le Coutre, P.; Fix, P.; Hopfer, O.; Junghanß, C.; Höffkes, H.; Heilmeier, B.; Möhle, R.; Lange, E. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing. (October 2020) Authors: Christopoulos, P.; Kirchner, M.; Roeper, J.; Saalfeld, F.; Janning, M.; Bozorgmehr, F.; Magios, N.; Kazdal, D.; Volckmar, A.L.; Brückner, L.M.; Bochtler, T.; Kriegsmann, M.; Endris, V.; Penzel, R.; Kriegsmann, K.; Eichhorn, M.; Herth, F.J.F.; Heussel, C.P.; El Shafie, R.A.; Schneider, M.A. Journal: Lung cancer Issue: Volume 148(2020) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗